Fatal Outcome of Imatinib in a Patient with Idiopathic Hypereosinophilic Syndrome

  • Abugroun A
  • Chaudhary A
  • Rodriguez G
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cytokine storm is a poorly explained clinical entity caused by an undesired and aggrandized immune system response leading to unregulated activation of the proinflammatory cascade, often contributing to multisystem organ failure and even death. Its potentially diverse etiologies and sepsis-like presentation have made it even more challenging to diagnose, and so far, no well-established treatment protocol has been proposed. Its association with certain medications, especially with monoclonal antibodies, has well been reported in literature. To the best of our knowledge, so far, no previous case of cytokine storm associated with imatinib has been reported. We herein present a case report of a 77-year-old male with a past medical history of hypereosinophilic syndrome who developed acute fatal cytokine storm following treatment with imatinib. This study highlights a life-threatening complication of the medication that may be underrecognized.

Cite

CITATION STYLE

APA

Abugroun, A., Chaudhary, A., & Rodriguez, G. (2018). Fatal Outcome of Imatinib in a Patient with Idiopathic Hypereosinophilic Syndrome. Case Reports in Oncological Medicine, 2018, 1–5. https://doi.org/10.1155/2018/6291614

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free